Clinical Trial Update: Safety and Tolerability Study of CTx1000 In Participants With Amyotrophic Lateral Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and tolerability of CTx1000 in participants with amyotrophic lateral sclerosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• CTx1000

Snippet

Sponsor: Celosia Therapeutics Pty Ltd | Conditions: ALS (Amyotrophic Lateral Sclerosis) | Phase 1 | Status: RECRUITING